KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Total Debt (2016 - 2025)

Historic Total Debt for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to $630.9 million.

  • Ionis Pharmaceuticals' Total Debt rose 131882.97% to $630.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $630.9 million, marking a year-over-year increase of 131882.97%. This contributed to the annual value of $51.9 million for FY2024, which is 3974.1% down from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Total Debt stood at $630.9 million for Q3 2025, which was up 131882.97% from $630.1 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Total Debt registered a high of $630.9 million during Q3 2025, and its lowest value of $8.8 million during Q1 2023.
  • In the last 5 years, Ionis Pharmaceuticals' Total Debt had a median value of $63.8 million in 2022 and averaged $136.1 million.
  • Its Total Debt has fluctuated over the past 5 years, first plummeted by 8616.1% in 2023, then soared by 131882.97% in 2025.
  • Ionis Pharmaceuticals' Total Debt (Quarter) stood at $63.2 million in 2021, then plummeted by 74.74% to $16.0 million in 2022, then skyrocketed by 439.46% to $86.2 million in 2023, then crashed by 39.74% to $51.9 million in 2024, then surged by 1115.07% to $630.9 million in 2025.
  • Its Total Debt was $630.9 million in Q3 2025, compared to $630.1 million in Q2 2025 and $51.9 million in Q4 2024.